Furthermore, elevated PD-L1+ M2 tumor-associated macrophages (CD45+ CSF1R+ CD68+ CD163+) also correlated with inferior outcomes in dCCA and higher expression of IL6, IL10, and ARG1, contributing to effector T cell suppression (Figure 1) (75). The gene discussed is CD274; the disease is neoplasm.